INARI MED INC's ticker is NARI and the CUSIP is 45332Y109. A total of 230 filers reported holding INARI MED INC in Q2 2022. The put-call ratio across all filers is 2.16 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $216,540 | -54.6% | 3,311 | -59.6% | 0.01% | -56.2% |
| Q2 2023 | $476,922 | +350577.9% | 8,203 | +272.2% | 0.02% | +300.0% |
| Q1 2023 | $136 | +83.8% | 2,204 | +91.0% | 0.00% | +33.3% |
| Q4 2022 | $74 | -100.0% | 1,154 | -87.3% | 0.00% | -72.7% |
| Q3 2022 | $660,000 | +33.9% | 9,080 | +25.3% | 0.01% | 0.0% |
| Q2 2022 | $493,000 | +297.6% | 7,246 | +428.9% | 0.01% | +1000.0% |
| Q1 2022 | $124,000 | -21.5% | 1,370 | -21.2% | 0.00% | -66.7% |
| Q4 2021 | $158,000 | +90.4% | 1,738 | +69.2% | 0.00% | +50.0% |
| Q3 2021 | $83,000 | +29.7% | 1,027 | +49.9% | 0.00% | 0.0% |
| Q2 2021 | $64,000 | -56.5% | 685 | -50.2% | 0.00% | 0.0% |
| Q1 2021 | $147,000 | -41.9% | 1,375 | -52.6% | 0.00% | -75.0% |
| Q4 2020 | $253,000 | +216.2% | 2,899 | +148.8% | 0.01% | +700.0% |
| Q3 2020 | $80,000 | – | 1,165 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Darsana Capital Partners LP | 1,475,000 | $137,588,000 | 3.91% |
| Affinity Asset Advisors, LLC | 85,000 | $7,929,000 | 2.84% |
| Parian Global Management LP | 49,800 | $4,645,000 | 1.99% |
| AlpInvest Partners B.V. | 27,960 | $2,608,000 | 1.28% |
| Sio Capital Management, LLC | 46,332 | $4,322,000 | 1.07% |
| HARBOURVEST PARTNERS LLC | 88,598 | $8,264,000 | 0.79% |
| HAMILTON LANE ADVISORS LLC | 26,403 | $2,463,000 | 0.77% |
| Pier Capital, LLC | 76,708 | $7,155,000 | 0.72% |
| Lisanti Capital Growth, LLC | 46,035 | $4,294,000 | 0.53% |
| NEXT CENTURY GROWTH INVESTORS LLC | 66,822 | $6,233,000 | 0.49% |